Literature DB >> 24314678

Spasticity management in multiple sclerosis.

Christina Hughes1, Ileana M Howard.   

Abstract

Spasticity is a prevalent and potentially disabling symptom common in individuals with multiple sclerosis. Adequate evaluation and management of spasticity requires a careful assessment of the patient's history to determine functional impact of spasticity and potential exacerbating factors, and physical examination to determine the extent of the condition and culpable muscles. A host of options for spasticity management are available: therapeutic exercise, physical modalities, complementary/alternative medicine interventions, oral medications, chemodenervation, and implantation of an intrathecal baclofen pump. Choice of treatment hinges on a combination of the extent of symptoms, patient preference, and availability of services.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antispasticity; Chemodenervation; Intrathecal baclofen; Multiple sclerosis; Spasticity

Mesh:

Substances:

Year:  2013        PMID: 24314678     DOI: 10.1016/j.pmr.2013.07.003

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN: 1047-9651            Impact factor:   1.784


  9 in total

1.  The 88-item Multiple Sclerosis Spasticity Scale: a Rasch validation of the Italian version and suggestions for refinement of the original scale.

Authors:  Leonardo Pellicciari; Marcella Ottonello; Andrea Giordano; Caterina Albensi; Franco Franchignoni
Journal:  Qual Life Res       Date:  2018-09-20       Impact factor: 4.147

Review 2.  Assessment and Measurement of Spasticity in MS: State of the Evidence.

Authors:  Cinda L Hugos; Michelle H Cameron
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-30       Impact factor: 5.081

Review 3.  Managing Disability in Progressive Multiple Sclerosis.

Authors:  Divyanshu Dubey; Peter Sguigna; Olaf Stüve
Journal:  Curr Treat Options Neurol       Date:  2016-06       Impact factor: 3.598

4.  A Cross-Sectional Study of the Impact of Spasticity on Daily Activities in Multiple Sclerosis.

Authors:  Francois Bethoux; Ruth Ann Marrie
Journal:  Patient       Date:  2016-12       Impact factor: 3.883

Review 5.  Intrathecal baclofen: effects on spasticity, pain, and consciousness in disorders of consciousness and locked-in syndrome.

Authors:  Francesca Pistoia; Simona Sacco; Marco Sarà; Marco Franceschini; Antonio Carolei
Journal:  Curr Pain Headache Rep       Date:  2015-01

Review 6.  Yoga as a method of symptom management in multiple sclerosis.

Authors:  Rachael Frank; Jennifer Larimore
Journal:  Front Neurosci       Date:  2015-04-30       Impact factor: 4.677

7.  Pharmacokinetic alteration of baclofen by multiple oral administration of herbal medicines in rats.

Authors:  Tae Hwan Kim; Gi-Young Park; Soyoung Shin; Dong Rak Kwon; Won Sik Seo; Jeong Cheol Shin; Jin Ho Choi; Sang Hoon Joo; Kwon-Yeon Weon; Byung Sun Min; Kyung Min Baek; Mahesh Upadhyay; Bing Tian Zhao; Mi Hee Woo; So Hee Kwon; Beom Soo Shin
Journal:  Evid Based Complement Alternat Med       Date:  2014-10-29       Impact factor: 2.629

8.  Cost analysis of glatiramer acetate versus interferon-β for relapsing-remitting multiple sclerosis in patients with spasticity: the Escala study.

Authors:  Rainel Sánchez-de la Rosa; Laura García-Bujalance; José Meca-Lallana
Journal:  Health Econ Rev       Date:  2015-10-16

Review 9.  Yoga as an intervention to manage multiple sclerosis symptoms.

Authors:  Priyanka Thakur; Ashu Mohammad; Yash Raj Rastogi; Reena V Saini; Adesh K Saini
Journal:  J Ayurveda Integr Med       Date:  2019-06-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.